Release Date: 12.06.2013
Presentation Type: Webinars
This interactive discussion on the history of pulmonary hypertension (PH) is the first presentation of a two-part series. It will focus on the evolution of our understanding of the mechanisms and physiology of PH. The webinar will consist of an interview with a panel of experts considered to be among the founders of the modern PH field. The second webinar in the series, History of PH: Progress in Clinical Management, will take place in early 2014 and will be posted on PHA Classroom.
Bruce Brundage, MD, is Emeritus Professor of Medicine at David Geffen UCLA, School of Medicine and served as Chief of Cardiology at Harbor-UCLA Medical Center. He received his MD at UMDNJ–New Jersey Medical School, completed his internship at Tripler Army Medical Center, Honolulu (rotating internship), his internal medicine residency at Fitzsimons Army Medical Center, Denver, and his cardiology fellowship at Letterman Army Medical Center, San Francisco. Dr. Brundage published over 150 peer-reviewed manuscripts and edited 2 textbooks. Throughout his career he received multiple research grants, and served as PI in the study that first demonstrated the effectiveness of calcium channel-blockers in reducing pulmonary artery pressures. He was the first Chair of PHA’s Scientific Leadership Council and the first physician to Chair PHA’s Board of Trustees.
C. Gregory Elliott, MD, is Professor of Medicine at the University of Utah School of Medicine and Chairman of the Department of Medicine at Intermountain Medical Center. He received his MD at the University of Maryland School of Medicine. His internship, residency, and Chief Medical Residency were completed at the University of Maryland Hospitals. His pulmonary and critical care fellowship was completed at the University of Utah School of Medicine. Dr. Elliott has authored or co-authored more than 90 original manuscripts in peer reviewed journals, in addition to numerous book chapters, editorials, and invited reviews. He is a past Chair of PHA's Scientific Leadership Council.
Stephen C. Mathai, MD, MHS, is Assistant Professor in the Division of Pulmonary and Critical Care at Johns Hopkins University School of Medicine. Dr. Mathai received his MD at Jefferson Medical College, and went on to complete his internship, residency and chief medical residency at Thomas Jefferson University Hospital. He then completed his fellowship in pulmonary and critical care medicine at Johns Hopkins University School of Medicine and his MHS in clinical investigation at Johns Hopkins Bloomberg School of Public Health. He has authored and reviewed many scholarly publications and serves as investigator in many research studies. Dr. Mathai is a current member of PHA’s Scientific Leadership Council.
Lewis J. Rubin, MD, is Emeritus Professor of Medicine at the University of California in San Diego, School of Medicine and its emeritus director of Pulmonary and Critical Care. Professor Rubin earned his medical degree from the Albert Einstein College of Medicine, New York, and completed a residency and fellowship at Duke University Medical Center. He has authored over 200 peer-reviewed publications and 70 book chapters, and edited six books on the pulmonary circulation. He has served as Principal Investigator/Steering Committee Chair or Member for the pivotal trials of most of the currently approved medical therapies for PAH. Dr. Rubin previously served as a member of PHA’s Scientific Leadership Council.